Our group
3D Cancer Models
Nano-sized Therapeutic and Diagnostic Tools for Cancer
Cancer Microenvironment
3D Bioprinting

Welcome to the Satchi-Fainaro Laboratory

about us

Combining multidisciplinary basic, translational and clinical approaches for cancer therapy

In our lab, we invest multidisciplinary efforts to elucidate the basic molecular mechanisms responsible for cancer progression to an aggressive, metastatic, drug-resistant phenotype in order to reveal new “druggable targets” for clinical translation. To achieve this goal, we exploit a rich platform of cell lines, ex vivo 3D models and in vivo mouse models of cancer as well as fresh and archived tissue specimens obtained from fruitful collaborations with several of TAU’s affiliated hospitals. We use a range of molecular and functional techniques to identify and validate new markers and drivers of cancer progression. The newly-gained knowledge is harnessed for the design of novel clinically-relevant polymer-based diagnostic and therapeutic tools for cancer. Our vision is that our multidisciplinary approach will revolutionize our perception of tumor progression and consequently the way we diagnose and treat cancer.

Photo by: Eric Sultan (Lady Globes)

Ronit Satchi-Fainaro, Ph.D.

Head, Cancer Research and Nanomedicine Laboratory

Kurt and Herman Lion Chair in Nanosciences and Nanotechnologies

Head of the TAU Kahn 3D Printing Initiative

The future is here

Watch the Satchi-Fainaro Lab on Ben-Shani's show, Kan 11

news and events

Forbes PowerWomen 2022
Forbes PowerWomen 2022June 2022
Read More
Prof. Satchi Fainaro was included in the 50 most powerful women list of the Forbes Journal
Best Publication Award - Sackler Faculty of Medicine​
Best Publication Award - Sackler Faculty of Medicine​April 2022
Read More
Prof. Satchi-Fainaro receives the 'Best Publication Award' for 2021 by the Faculty of Medicine, Tel Aviv University
CRS 2022 College of Fellows Inductees​
CRS 2022 College of Fellows Inductees​April 2022
Read More
Prof. Satchi-Fainaro was announces as one of the 2022 New College of Fellows Members of the Controlled Release Society (CRS)
Editor’s choice section
Editor’s choice sectionApril 2022
Read More
Our review on Gliblastoma in Advanced Therapeutics has been chosen by the editorial team to be featured in the Editor’s Choice section
3D Printing Industry Award
3D Printing Industry AwardNovember 2021
Read More
Prof. Ronit Satchi-Fainaro wins the 3D Printing Industry Award as the Healthcare applicaton of the year!
Salisbury Award
Salisbury AwardMay 2021
Read More
Prof. Satchi Fainaro receives the Salisbury Award for Entrepreneurial Translational Research by the National Foundation for Cancer Research (NFCR).
Bruno Award
Bruno AwardJune 2020
Read More
Prof Ronit Satchi-Fainaro receives the Michael Bruno Memorial Award.

One of the seven collaborations between architects and biologists. Architectural Speculation: Urban Angiogenesis, Knafo Klimor Architects & Prof. Ronit Satchi-Fainaro, 2016. 

“New Revelations that Will Bring a Revolution” – a lecture in tribute of Bob Marley who died of cancer (in Hebrew)

“Nano GPS for personalized theranostics” – a lecture (in Hebrew) given as a part the Tel Aviv University event on the “White Night” that took place at Tel Aviv Port. 


Our new paper on the role of MCP-1/CCR2 axis in melanoma brain metastases is out

MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression.

Sep 2022 | JCI Insight

Polyglutamate-based nanoconjugates for image-guided surgery and post-operative melanoma metastases prevention.

Aug 2022 | Theranostics

Sulfonated Amphiphilic Poly(α)glutamate Amine-A Potential siRNA Nanocarrier for the Treatment of Both Chemo-Sensitive and Chemo-Resistant Glioblastoma Tumors

Dec 2021 | Pharmaceutics

Join Our Team!

Our lab is seeking for highly motivated and talented postdocs with background in cancer biology, chemistry or chemical engineering

Copyright © 2019 Satchi-Fainaro Lab. All Rights Reserved 

 Designed by Galia.T